Physician profile
Benjamin R Kuhn
NPI 1497878680
$199,199.62
in general payments reported to CMS, 2019-2025
13 companies · $113K in 2025
The $113K reported for 2025 was more than what 99% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $125 · 2021: $85.02 · 2022: $246 · 2023: $22K · 2024: $63K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $178K · Travel and Lodging: $17K · Food and Beverage: $3,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $178,045.00 |
| Travel and Lodging | $17,061.93 |
| Food and Beverage | $3,436.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $177,898.02 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $20,525.16 | 2023-2025 | Dupixent |
| Laborie Medical Technologies Corp. | $166.57 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $141.22 | 2020-2025 | Gattex |
| Genentech USA, INC. | $125.00 | 2019 | |
| Sanofi Pasteur INC. | $85.02 | 2021 | |
| Pfizer INC. | $61.51 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $49.68 | 2025 | Dupixent |
| Celgene Corporation | $41.04 | 2024 | Zeposia |
| Neuraxis, INC. | $35.87 | 2024 | |
| Qol Medical, LLC | $32.96 | 2019-2022 | |
| Neurelis, INC. | $22.20 | 2023 | Valtoco |
| Abbvie INC. | $15.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kuhn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.